Cargando…

P608: THE EXPRESSION OF CYTOR LNCRNA HAS POOR PROGNOSTIC VALUE IN CLL PATIENTS AND IS ASSOCIATED WITH MICROENVIRONMENTAL STIMULI.

Detalles Bibliográficos
Autores principales:	Hernández, Lluís, Nadeu, Ferran, Delgado, Julio, Duran-Ferrer, Martí, Rafael Romero, Dario, Orellana Fernández, Ruth, Bittolo, Tamara, Bomben, Riccardo, Gattei, Valter, Campo, Elias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429169/ http://dx.doi.org/10.1097/01.HS9.0000969336.43991.83

Ejemplares similares

KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders
por: Vendramini, Elena, et al.
Publicado: (2022)

Circulating CYTOR as a Potential Biomarker in Breast Cancer
por: Moradi, Mohammad-Taher, et al.
Publicado: (2020)

ENO2 Promotes Colorectal Cancer Metastasis by Interacting with the LncRNA CYTOR and Activating YAP1-Induced EMT
por: Lv, Chunwei, et al.
Publicado: (2022)

lncRNA cytoskeleton regulator RNA (CYTOR): Diverse functions in metabolism, inflammation and tumorigenesis, and potential applications in precision oncology
por: Ou, Chunlin, et al.
Publicado: (2021)

Microenvironmental stimuli for proliferation of functional islet β-cells
por: Alismail, Hanan, et al.
Publicado: (2014)

Editorial: Microenvironmental stimuli-responsive nanomedicine for biomedical application
por: Xia, Donglin, et al.
Publicado: (2023)

P606: MEASUREMENT OF INTRACLONAL DIVERSIFICATION REFINES THE PROGNOSTIC IMPACT OF IGHV MUTATIONS IN CLL
por: Vit, Filippo, et al.
Publicado: (2023)

P594: THE CXCR4-LOW/CD5-HIGH PROLIFERATIVE FRACTION IS ENRICHED IN BTK MUTATIONS AND ANTICIPATES RELAPSE IN IBRUTINIB-TREATED CLL
por: Pozzo, Federico, et al.
Publicado: (2023)

lncRNA CYTOR promotes tamoxifen resistance in breast cancer cells via sponging miR-125a-5p
por: Liu, Yungyong, et al.
Publicado: (2020)

Multiple Mechanisms of NOTCH1 Activation in Chronic Lymphocytic Leukemia: NOTCH1 Mutations and Beyond
por: Pozzo, Federico, et al.
Publicado: (2022)

Microenvironmental stimuli induce different macrophage polarizations in experimental models of emphysema
por: Kohler, Júlia Benini, et al.
Publicado: (2019)

lncRNA CYTOR promotes aberrant glycolysis and mitochondrial respiration via HNRNPC-mediated ZEB1 stabilization in oral squamous cell carcinoma
por: Zhu, Weiwen, et al.
Publicado: (2022)

Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study
por: Bomben, Riccardo, et al.
Publicado: (2023)

All-CLL: A Capture-based Next-generation Sequencing Panel for the Molecular Characterization of Chronic Lymphocytic Leukemia
por: López-Oreja, Irene, et al.
Publicado: (2023)

TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed?
por: Bomben, Riccardo, et al.
Publicado: (2023)

Long non-coding RNA (lncRNA) CYTOR promotes hepatocellular carcinoma proliferation by targeting the microRNA-125a-5p/LASP1 axis
por: Liu, Yadong, et al.
Publicado: (2022)

LncRNA CYTOR affects the proliferation, cell cycle and apoptosis of hepatocellular carcinoma cells by regulating the miR-125b-5p/KIAA1522 axis
por: Hu, Bo, et al.
Publicado: (2020)

lncRNA CYTOR Facilitates Osteogenic Differentiation of Human Periodontal Ligament Stem Cells by Modulating SOX11 via Sponging miR-6512-3p
por: Tu, Shaoqin, et al.
Publicado: (2023)

The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68
por: Wang, Xue, et al.
Publicado: (2018)

The Emerging Role of Tumor Microenvironmental Stimuli in Regulating Metabolic Rewiring of Liver Cancer Stem Cells
por: Correnti, Margherita, et al.
Publicado: (2022)

Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies
por: Delgado, Julio, et al.
Publicado: (2020)

Microenvironmental contributions to hematopoietic stem cell aging
por: Ho, Ya-Hsuan, et al.
Publicado: (2020)

Memorandum: clarification of R608 triggering requirements
por: Diamant-Berger, Alain M, et al.
Publicado: (1979)

R608 at intersection I6, ISR
Publicado: (1980)

Up-regulation of long non-coding RNA CYTOR induced by icariin promotes the viability and inhibits the apoptosis of chondrocytes
por: Wang, Guoyou, et al.
Publicado: (2021)

CYTOR drives prostate cancer progression via facilitating AR‐V7 generation and its oncogenic signalling
por: Yu, Jianpeng, et al.
Publicado: (2023)

The MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential
por: Dal Bo, Michele, et al.
Publicado: (2015)

Critical molecular pathways in CLL therapy
por: Ferrer, Gerardo, et al.
Publicado: (2018)

P597: XPO1 MUTATIONS IDENTIFY EARLY STAGE CLL CHARACTERIZED BY SHORTER TIME TO FIRST TREATMENT AND ENHANCED BCR SIGNALING
por: Talotta, Donatella, et al.
Publicado: (2023)

In Vivo and In Vitro Expression of Tenascin by Human Thymic Microenvironmental Cells
por: Freitas, Claudia Sondermann, et al.
Publicado: (1995)

Targeted chitosan nanobubbles as a strategy to down-regulate microRNA-17 into B-cell lymphoma models
por: Capolla, Sara, et al.
Publicado: (2023)

Microenvironmental Targets in Sarcoma
por: Ehnman, Monika, et al.
Publicado: (2015)

Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report
por: Cuneo, Antonio, et al.
Publicado: (2020)

IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling
por: Maity, Palash C., et al.
Publicado: (2020)

Setting up R608 at intersection I6, ISR
por: CERN PhotoLab
Publicado: (1980)

Physics with $\overline{p}p$ collisions in Experiment R 608
por: Schlein, P E
Publicado: (1979)

Competing targets of microRNA-608 affect anxiety and hypertension
por: Hanin, Geula, et al.
Publicado: (2014)

Competing targets of microRNA-608 affect anxiety and hypertension
por: Hanin, Geula, et al.
Publicado: (2014)

MiR-608 overexpression in idiopathic pulmonary fibrosis (IPF)
por: Epstein Shochet, Gali, et al.
Publicado: (2021)

Biological Functions and Molecular Mechanisms of MiR-608 in Cancer
por: Lu, Juan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_taucshoqg17davg9r17hl7h24p